has semaglutide killed anyone Doctors warn some popular weight-loss drugs may raise risk of complications under anesthesia The Boom in New Weight

The 23-time Grand Slam winner opens up about her decision to go on the weight management drug.

Tirzepatide, Zepbound, and Mounjaro injection-site rashes affect roughly 3-7% of users in clinical trials

One study showed that there were 1 million new GLP-1 receptor agonists users from 2011 to

The authors found that the number of GLP-1 expressing cells is consistently reduced at the site of active disease in both mouse models of intestinal inflammation and in CD patients, as confirmed by the single-cell RNA sequencing data

Tirzepatide acts as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptor agonist, making it an effective treatment of type 2 diabetes with hypoglycemic and we...